Rafferty Asset Management
GILD icon

Rafferty Asset Management’s Gilead Sciences GILD Stock Holding History

Rafferty Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$29.5M Sell
212,014
-71,188
-25% -$9.97M 0.12% 93
2025
Q4 		$34.8M Sell
283,202
-31,686
-10% -$3.85M 0.12% 100
2025
Q3 		$35M Sell
314,888
-13,112
-4% -$1.49M 0.11% 102
2025
Q2 		$36.4M Sell
328,000
-803
-0.2% -$85.5K 0.12% 93
2025
Q1 		$36.8M Sell
328,803
-96,670
-23% -$9.97M 0.16% 89
2024
Q4 		$39.3M Sell
425,473
-45,099
-10% -$4.06M 0.14% 90
2024
Q3 		$39.5M Sell
470,572
-125,625
-21% -$9.59M 0.14% 86
2024
Q2 		$40.9M Buy
596,197
+176,519
+42% +$11.8M 0.15% 80
2024
Q1 		$30.7M Buy
419,678
+44,530
+12% +$3.42M 0.11% 101
2023
Q4 		$30.4M Buy
375,148
+16,626
+5% +$1.29M 0.13% 97
2023
Q3 		$26.9M Buy
358,522
+41,064
+13% +$3.16M 0.16% 86
2023
Q2 		$24.5M Buy
317,458
+52,935
+20% +$4.22M 0.14% 95
2023
Q1 		$21.9M Buy
264,523
+13,576
+5% +$1.12M 0.15% 98
2022
Q4 		$21.5M Sell
250,947
-24,915
-9% -$1.97M 0.18% 98
2022
Q3 		$17M Buy
275,862
+72,281
+36% +$4.56M 0.18% 93
2022
Q2 		$12.6M Sell
203,581
-38,206
-16% -$2.37M 0.12% 104
2022
Q1 		$14.4M Buy
241,787
+67,505
+39% +$4.32M 0.09% 146
2021
Q4 		$12.7M Buy
174,282
+31,602
+22% +$2.18M 0.07% 154
2021
Q3 		$9.97M Buy
142,680
+21,980
+18% +$1.54M 0.07% 165
2021
Q2 		$8.31M Sell
120,700
-14,534
-11% -$970K 0.05% 211
2021
Q1 		$8.74M Buy
135,234
+33,187
+33% +$2.14M 0.06% 182
2020
Q4 		$5.95M Buy
102,047
+2,747
+3% +$166K 0.06% 185
2020
Q3 		$6.28M Buy
99,300
+18,409
+23% +$1.28M 0.08% 156
2020
Q2 		$6.22M Buy
80,891
+22,544
+39% +$1.73M 0.09% 136
2020
Q1 		$4.36M Sell
58,347
-71,270
-55% -$4.92M 0.18% 65
2019
Q4 		$8.42M Sell
129,617
-2,156
-2% -$140K 0.13% 87
2019
Q3 		$8.35M Sell
131,773
-30,365
-19% -$1.98M 0.13% 87
2019
Q2 		$11M Buy
162,138
+50,523
+45% +$3.32M 0.19% 63
2019
Q1 		$7.26M Buy
111,615
+85,682
+330% +$5.69M 0.12% 92
2018
Q4 		$1.62M Sell
25,933
-1,842
-7% -$129K 0.04% 266
2018
Q3 		$2.15M Buy
27,775
+1,398
+5% +$106K 0.03% 276
2018
Q2 		$1.87M Buy
26,377
+6,034
+30% +$426K 0.03% 305
2018
Q1 		$1.53M Buy
20,343
+531
+3% +$42.2K 0.02% 376
2017
Q4 		$1.42M Buy
19,812
+828
+4% +$62.9K 0.02% 367
2017
Q3 		$1.54M Sell
18,984
-3,322
-15% -$254K 0.03% 312
2017
Q2 		$1.58M Buy
22,306
+5,657
+34% +$376K 0.05% 238
2017
Q1 		$1.13M Buy
16,649
+3,061
+23% +$215K 0.02% 329
2016
Q4 		$973K Buy
13,588
+4,272
+46% +$318K 0.04% 224
2016
Q3 		$737K Buy
9,316
+2,204
+31% +$179K 0.03% 251
2016
Q2 		$593K Sell
7,112
-1,516
-18% -$135K 0.04% 318
2016
Q1 		$793K Buy
8,628
+139
+2% +$12.5K 0.04% 297
2015
Q4 		$867K Sell
8,489
-21,601
-72% -$2.25M 0.1% 254
2015
Q3 		$2.96M Buy
30,090
+11,905
+65% +$1.32M 0.23% 78
2015
Q2 		$2.13M Buy
18,185
+7,608
+72% +$831K 0.14% 93
2015
Q1 		$1.04M Buy
10,577
+4,319
+69% +$439K 0.08% 222
2014
Q4 		$590K Sell
6,258
-322
-5% -$33.3K 0.13% 164
2014
Q3 		$700K Buy
6,580
+1,824
+38% +$179K 0.08% 95
2014
Q2 		$394K Sell
4,756
-1,579
-25% -$123K 0.08% 188
2014
Q1 		$449K Sell
6,335
-42
-0.7% -$3.29K 0.09% 97
2013
Q4 		$479K Buy
+6,377
New +$444K 0.11% 113

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Rafferty Asset Management's GILD Position: Q1 2026 in Review

Rafferty Asset Management reduced its Gilead Sciences (GILD) stake by 25% in Q1 2026, selling an estimated $9.97M and leaving 212,014 shares worth $29.5M. The position accounts for 0.12% of the portfolio, ranked #93.

Rafferty Asset Management first reported a position in GILD in Q4 2013 and has held it in 50 quarters since. The position peaked at $40.9M in Q2 2024. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Rafferty Asset Management held 212,014 shares of Gilead Sciences worth $29.5M as of Q1 2026.
  • Rafferty Asset Management sold 71,188 Gilead Sciences shares in Q1 2026, an estimated $9.97M.
  • Gilead Sciences made up 0.12% of Rafferty Asset Management's portfolio in Q1 2026, its #93 holding.
  • Rafferty Asset Management first reported a position in Gilead Sciences in Q4 2013 and has held it in 50 quarters since.
  • Rafferty Asset Management's Gilead Sciences position peaked at $40.9M in Q2 2024.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Rafferty Asset Management's 13F filing for Q1 2026, filed 15 May 2026.